Current Techniques in Monoclonal Antibody Development
As the complexity of mAbs continues to grow, developers explore the potential of new techniques and expression systems. The development of mAbs (monoclonal antibodies) has come a long way since 1986, when the first mAb, Orthoclone OKT3, received approval for clinical use. Over the past 30 years, mAb production has become streamlined, efficient, and highly [...]